Product
MTX
4 clinical trials
3 indications
Indication
Juvenile Idiopathic ArthritisIndication
Rheumatoid ArthritisIndication
Tubal PregnancyClinical trial
A Phase IV, Multicenter, Single-Arm, Open-Label Study to Assess the Efficacy and Safety of Tocilizumab in Chinese Patients With Systemic Juvenile Idiopathic ArthritisStatus: Completed, Estimated PCD: 2021-09-04
Clinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate Safety and Clinical Efficacy of Two Different Doses of F8IL10 (Dekavil) Administered Subcutaneously to Patients With Active Rheumatoid Arthritis Receiving Methotrexate.Status: Terminated, Estimated PCD: 2019-04-01
Clinical trial
A Randomized, Multi-Center, Double Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of Subcutaneous (SC) Tocilizumab (TCZ) in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Patients With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current DMARD TherapyStatus: Completed, Estimated PCD: 2022-08-08
Clinical trial
Management of Tubal Pregnancy With Off-label Use of Letrozole in MonotherapyStatus: Completed, Estimated PCD: 2022-12-30